0001181431-13-013600.txt : 20130301 0001181431-13-013600.hdr.sgml : 20130301 20130301162023 ACCESSION NUMBER: 0001181431-13-013600 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130228 FILED AS OF DATE: 20130301 DATE AS OF CHANGE: 20130301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Siegel Eric H. CENTRAL INDEX KEY: 0001527573 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 13657907 MAIL ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY RD., BLDG. E336 STREET 2: C/O INCYTE CORP., EXPERIMENTAL STATION CITY: WILMINGTON STATE: DE ZIP: 19880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 4 1 rrd372350.xml X0306 4 2013-02-28 0 0000879169 INCYTE CORP INCY 0001527573 Siegel Eric H. EXPERIMENTAL STATION ROUTE 141 AND HENRY CLAY RD WILMINGTON DE 19880 0 1 0 0 EVP, General Counsel Common Stock 2013-02-28 4 M 0 5202 16.66 A 5482 D Common Stock 2013-02-28 4 M 0 17020 16.66 A 22502 D Common Stock 2013-02-28 4 M 0 11110 14.72 A 33612 D Common Stock 2013-02-28 4 M 0 12499 14.0 A 46111 D Common Stock 2013-02-28 4 M 0 4169 17.79 A 50280 D Common Stock 2013-02-28 4 S 0 50000 22.16 D 280 D Incentive Stock Option (right to buy) 16.66 2013-02-28 4 M 0 5202 0 D 2017-10-28 Common Stock 5202 4802 D Non-Qualified Stock Option (right to buy) 16.66 2013-02-28 4 M 0 17020 0 D 2017-10-28 Common Stock 17020 12977 D Non-Qualified Stock Option (right to buy) 14.72 2013-02-28 4 M 0 11110 0 D 2018-01-24 Common Stock 11110 11111 D Non-Qualified Stock Option (right to buy) 14.0 2013-02-28 4 M 0 12499 0 D 2018-08-07 Common Stock 12499 6945 D Non-Qualified Stock Option (right to buy) 17.79 2013-02-28 4 M 0 4169 0 D 2019-01-18 Common Stock 4169 68419 D Beginning October 29, 2010, options become exercisable in 25 installments, with the first intallment of 33.33% vesting after one year and the remaining vesting monthly over two years. Beginning January 25, 2011, options become exercisable in 25 installments, with the first intallment of 33.33% vesting after one year and the remaining vesting monthly over two years. Represents weighted average sale price. Actual sales prices ranged from $22.07 to $22.25. Beginning August 9, 2011, options become exercisable in 25 installments, with the first intallment of 33.33% vesting after one year and the remaining vesting monthly over two years. Beginning January 19, 2012, options become exercisable in 25 installments, with the first intallment of 33.33% vesting after one year and the remaining vesting monthly over two years. /s/ Eric Siegel 2013-03-01